Document is current
Any future updates will be listed below
-
Authors
Kamigaki, Yu
Dougherty, Julie A.
Waller, Amanda P.
Wolfgang, Katelyn J.
Rehaume, Linda M.
Cross, Jennifer L.
Zhou, Simon
Biederman, Laura E.
Stevenson, Zackary S.
Abdelghani, Eman
Kerlin, Bryce A.
Smoyer, William E.
-
Funding
Funding for this research was provided by:
Aurinia Pharmaceuticals Inc
National Institute of Diabetes and Digestive and Kidney Diseases (DK 124549)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 095059)
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 11 February 2026
First Online: 24 February 2026
Declarations
:
: Animal studies and procedures were approved by the Nationwide Children’s Hospital Institutional Animal Care and Use Committee (protocol AR21-00064) and performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
: Not applicable.
: WES is on the Board of Directors of NephCure and receives no compensation as a board member. SZ, LMR, and JLC are employees and shareholders of Aurinia Pharmaceuticals Inc. All other authors have no disclosures.
